Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
Crossref DOI link: https://doi.org/10.1007/s10549-016-4081-8
Published Online: 2016-12-22
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shiao, J.
Thomas, K. M.
Rahimi, A. S.
Rao, R.
Yan, Jingsheng
Xie, Xian-Jin
DaSilva, M.
Spangler, A.
Leitch, M.
Wooldridge, R.
Rivers, A.
Farr, D.
Haley, B.
Kim, D. W. Nathan
License valid from 2016-12-22